We are looking forward to LINC 2020 in Leipzig, Germany for many reasons – it’s a top international vascular conference and we’re still craving glühwein in these cold winter months – but above all, we’re excited to announce the lineup for our very first ever Shockwave IVL Booth Speaker Series!
We are honored to have six esteemed IVL-expert physicians speaking at our Shockwave IVL booth on the first three days of the conference, 28-30 January. These speakers will share their broad and unique applications of our technology for treating cardiovascular calcium. Check out these headliners, and join us at the booth to learn how IVL cracks calcium from the Iliacs to the ankles!
Tuesday, 28 January
George Adams presenting Treatment of calcified tibial disease with IVL @ 11:10
Arne Schwindt presenting IVL Facilitated EVAR and TEVAR Delivery @ 12:45
Wednesday, 29 January
Thursday, 30 January
In addition to our in-booth speaker series, we are very excited to have three IVL sessions in the Main LINC Program. Mark your calendars to attend these three IVL-focused sessions as well.
Tuesday, 28 January @ 15:15
Room 7 Speakers corner
Thursday, 30 January @ 15:50
Room 1, Main Arena
Thursday, 30 January @ 17:25
Room 1, Main Arena
Don’t forget to visit us at our Shockwave booth for a demo, and if you aren’t already, make sure to follow us on Twitter at @ShockwaveIVL to keep up with the latest news and events.
Contact Us on our website if you have any questions about IVL or if you’d like to setup a time to meet at LINC 2020.
See you soon!
Important Safety Information
Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.
Indication for Use – The Shockwave Medical Intravascular Lithotripsy (IVL) System is intended for lithotripsy-enhanced balloon dilatation of lesions, including calcified lesions, in the peripheral vasculature, including the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries. Not for use in the coronary or cerebral vasculature.
Contraindications – Do not use if unable to pass 0.014 guidewire across the lesion • Not intended for treatment of in-stent restenosis or in coronary, carotid, or cerebrovascular arteries.
Warnings – Only to be used by physicians who are familiar with interventional vascular procedures • Physicians must be trained prior to use of the device • Use the Generator in accordance with recommended settings as stated in the Operator’s Manual
Precautions – Use only the recommended balloon inflation medium • Appropriate anticoagulant therapy should be administered by the physician • Decision regarding use of distal protection should be made based on physician assessment of treatment lesion morphology
Adverse Effects – Possible adverse effects consistent with standard angioplasty include: • Access site complications • Allergy to contrast or blood thinners • Arterial bypass surgery • Bleeding complications • Death • Fracture of guidewire or device • Hypertension/Hypotension • Infection/sepsis • Placement of a stent • Renal failure • Shock/pulmonary edema • Target vessel stenosis or occlusion • Vascular complications. Risks unique to the device and its use: • Allergy to catheter material(s) • Device malfunction or failure • Excess heat at target site
Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions, and adverse events. www.shockwavemedical.com